Trials / Unknown
UnknownNCT01382199
Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
A Phase III Randomized, Double Blind, Placebo Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 340 (estimated)
- Sponsor
- Ventria Bioscience · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lactoferrin |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2013-09-01
- Completion
- 2014-03-01
- First posted
- 2011-06-27
- Last updated
- 2011-06-27
Source: ClinicalTrials.gov record NCT01382199. Inclusion in this directory is not an endorsement.